#PreclinicalTrials

Matt WillemsenNonog@fedibird.com
2023-05-27

Readily Available Dietary Supplement Reverses HIV-Related Organ Damage in Preclinical Trials
MitoQ, a publicly accessible dietary supplement that acts as a mitochondrial antioxidant, was discovered through a mouse study to counteract the harmful impacts that HIV and antiretroviral therapy (ART) inflict on the mitochondria within the brain, heart, aorta, lungs, kidney, and liver.
scitechdaily.com/readily-avail #DietarySupplement#HIV #OrganDamage #PreclinicalTrials #MitoQ

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst